• Ishaq Lat, Craig M Coopersmith, Daniel De Backer, Research Committee of the Surviving Sepsis Campaign, Members of the Surviving Sepsis Campaign Research Committee contributing to this article are as follows, Co-chair, Atlanta, GA, Co-chair, Brussels, Belgium, Manhasset, NY, Consultant, Seattle, WA, Barcelona, Spain, San Francisco, CA, Pune, India, Utrecht, the Netherlands, Chicago, IL, Sao Paulo, Brazil, Atlanta, GA, Dublin, Ireland, New York, NY, Consultant, London, United Kingdom., and Research Committee of the Surviving Sepsis Campaign and Members of the Surviving Sepsis Campaign Research Committee contributing to this article are as follows and Co-chair, Atlanta, GA and Co-chair, Brussels, Belgium and Manhasset, NY and Consultant, Sea.
• Department of Pharmacy, Shirley Ryan AbilityLab, Chicago, IL.
• Crit. Care Med. 2021 Apr 1; 49 (4): 623635623-635.

ObjectiveExpand upon the priorities of fluid resuscitation and vasopressor therapy research priorities identified by a group of experts assigned by the Society of Critical Care Medicine and the European Society of Intensive Care Medicine.Data SourcesOriginal article, literature search.Study SelectionSeveral members of the original task force with expertise specific to the area of fluid resuscitation and vasopressor therapy.Data ExtractionNone.Data SynthesisNone.ConclusionIn the second of a series of manuscripts subsequent to the original article, members with expertise in the subjects expound upon the three identified priorities related to fluid resuscitation and vasopressor therapies. This analysis summarizes what is known and what were identified as ongoing and future research.Copyright © 2021 The Author(s). Published by Wolters Kluwer Health, Inc. on behalf of the Society of Critical Care Medicine and Wolters Kluwer Health, Inc.

16 keywords...

hide…